The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
The Experimental and Clinical Pharmacology of Propofol, an Anesthetic Agent with Neuroprotective Properties
Open accessAbstract
Propofol (2,6‐diisopropylphenol) is a versatile, short‐acting, intravenous (i.v.) sedative‐hypnotic agent initially marketed as an anesthetic, and now also widely used for the sedation of patients in the intensive care unit (ICU). At the room temperature propofol is an oil and is insoluble in water. It has a remarkable safety profile. Its most common side effects are dose‐dependent hypotension and cardiorespiratory depression. Propofol is a global central nervous system (CNS) depressant. It activates γ‐aminobutyric acid (GABA A) receptors directly, inhibits the N‐methyl‐d‐aspartate (NMDA) receptor and modulates calcium influx through slow calcium‐ion channels. Furthermore, at doses that do not produce sedation, propofol has an anxiolytic effect. It has also immunomodulatory activity, and may, therefore, diminish the systemic inflammatory response believed to be responsible for organ dysfunction. Propofol has been reported to have neuroprotective effects. It reduces cerebral blood flow and intracranial pressure (ICP), is a potent antioxidant, and has antiinflammatory properties. Laboratory investigations revealed that it might also protect brain from ischemic injury. Propofol formulations contain either disodium edetate (EDTA) or sodium metabisulfite, which have antibacterial and antifungal properties. EDTA is also a chelator of divalent ions such as calcium, magnesium, and zinc. Recently, EDTA has been reported to exert a neuroprotective effect itself by chelating surplus intracerebral zinc in an ischemia model. This article reviews the neuroprotective effects of propofol and its mechanism of action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Role of Zinc in Selective Neuronal Death After Transient Global Cerebral Ischemia
Koh, J.-Y., Suh, S. W., Gwag, B. J., He, Y. Y., Hsu, C. Y., & Choi, D. W. (1996) · Science · doi:10.1126/science.272.5264.1013 · Cited by 1,071
Propofol: Therapeutic Indications and Side-Effects
Marik, P. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043382846 · Cited by 563
Postoperative Infections Traced to Contamination of an Intravenous Anesthetic, Propofol
Bennett, S. N., McNeil, M. M., Bland, L. A., Arduino, M. J., Villarino, M. E., Perrotta, D. M., Burwen, D. R., Welbel, S. F., Pegues, D. A., Stroud, L., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507203330303 · Cited by 497
Propofol: An Update of its Use in Anaesthesia and Conscious Sedation
Bryson, H. M., Fulton, B. R., & Faulds, D. (1995) · Drugs · doi:10.2165/00003495-199550030-00008 · Cited by 374
Langley, M. S., & Heel, R. C. (1988) · Drugs · doi:10.2165/00003495-198835040-00002 · Cited by 308
Barrientos-Vega, R., Sanchez-Soria, M. M., Morales-Garcia, C., Robas-Gomez, A., Cuena-Boy, R., & Ayensa-Rincon, A. (1997) · Critical Care Medicine · doi:10.1097/00003246-199701000-00009 · Cited by 286
MK-801 is neuroprotective in gerbils when administered during the post-ischaemic period
Gill, R., Foster, A. C., & Woodruff, G. N. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90040-1 · Cited by 276
Orser, B. A., Bertlik, M., Wang, L., & MacDonald, J. F. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb16660.x · Cited by 249
Park, C. K., Nehls, D. G., Graham, D. I., Teasdale, G. M., & McCulloch, J. (1988) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1988.124 · Cited by 244
Zinc neurotoxicity in cortical cell culture
Choi, D. W., Yokoyama, M., & Koh, J. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90312-0 · Cited by 244
Cited by
Sartiani, L., Mannaioni, G., Masi, A., Novella Romanelli, M., & Cerbai, E. (2017) · Pharmacological Reviews · doi:10.1124/pr.117.014035 · Cited by 143
Richards, J. R., Albertson, T. E., Derlet, R. W., Lange, R. A., Olson, K. R., & Horowitz, B. Z. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.01.040 · Cited by 107
HCN Channels Modulators: The Need for Selectivity
Novella Romanelli, M., Sartiani, L., Masi, A., Mannaioni, G., Manetti, D., Mugelli, A., & Cerbai, E. (2016) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026616999160315130832 · Cited by 73
“8) is an intravenous sedative-hypnotic agent for use in the induction and maintenance of anaesthesia; it activates GABA-A receptors, but it acts also on other targets, such as, for instance NMDA receptors [153].”
BackgroundPropofol facilitates glutamatergic transmission to neurons of the ventrolateral preoptic nucleus
Li, K. Y., Guan, Y.-Z., Krnjević, K., & Ye, J. H. (2009) · Anesthesiology · doi:10.1097/aln.0b013e3181bf1d79 · Cited by 45
Sedation in the emergency department: A complex and multifactorial challenge
Kennedy, R. M. (2015) · Pediatric Sedation Outside of the Operating Room · doi:10.1007/978-1-4939-1390-9_19 · Cited by 4
Metadata
- Authors
- Kotani, Y., Shimazawa, M., Yoshimura, S., Iwama, T., & Hara, H.
- Venue
- CNS Neuroscience & Therapeutics
- Publisher
- Wiley
- Published
- 2008-05-14
- Volume
- 14
- Issue
- 2
- Pages
- 95-106
- ISSN
- 1755-5930 (ISSN-L)
- 1755-5949
- OpenAlex
- W2066601004
- Cited by
- 302
- References
- 51
- FWCI
- 8.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Experimental and Clinical Pharmacology of Propofol, an Anesthetic Agent with Neuroprotective Properties. https://app.cochat.ai/papers/10.1111/j.1527-3458.2008.00043.x
- The paper
- Kotani, Y., Shimazawa, M., Yoshimura, S., Iwama, T., & Hara, H. (2008). The Experimental and Clinical Pharmacology of Propofol, an Anesthetic Agent with Neuroprotective Properties. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/j.1527-3458.2008.00043.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.